Close Menu

NEW YORK (GenomeWeb) – Abbott Laboratories attempted to terminate its pending merger with Alere, Alere said late on Thursday. 

The firm has twice delayed filing its 2015 earnings report, leading Abbott to inform Alere that "it has serious concerns about, among other things, the accuracy of various representations, warranties and covenants made by Alere in the parties' merger agreement," Alere said. Abbott even offered to pay Alere a termination fee of $30 million to $50 million to pay for Alere's transaction expenses.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Retraction Watch writes that a cancer researcher has had an eighth paper retracted.

Computational biologist James Taylor has died, according to Johns Hopkins University.

The Centers for Disease Control and Prevention is starting to test people for SARS-CoV-2 antibodies, according to the New York Times.

In PLOS this week: features of tumor-infiltrating immune cells, regulatory effects of SNPs associated with prostate cancer risk, and more.